Navigation Links
Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
Date:10/2/2008

Study to support Urgent PC clinical success and expanded reimbursement

coverage

MINNEAPOLIS, Oct. 2 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today the enrollment of the first patients in a new randomized, controlled multicenter clinical study of its FDA cleared Urgent PC neuromodulation system for the treatment of overactive bladder (OAB) symptoms of urinary urgency, urge incontinence and frequency of urinary voids.

The study is designed to directly compare the effectiveness of Urgent PC treatment to non-active treatment. Uroplasty is undertaking this study primarily to support third-party reimbursement coverage. The study will evaluate reductions in urinary urgency, urge incontinence and frequency of urinary voids, as well as patient quality of life measures. This study, expected to be completed by early fall of 2009, is to take place at approximately 20 urology and urogynecology centers across the United States, with total enrollment of 214 patients. As previously discussed, Uroplasty has reallocated expenditures this fiscal year to expedite these efforts, and expects to spend between $1.0 million and $1.4 million this fiscal year on the study.

More than 33 million Americans suffer from OAB symptoms, dramatically impacting the quality of their lives. The Urgent PC system is a minimally invasive, office-based, nonsurgical, percutaneous tibial nerve stimulation (PTNS) device that treats these symptoms. The Company believes physicians, patients and many third party payers are embracing the Urgent PC therapy because this low cost, non-surgical, non-drug treatment alternative is clinically effective.

Kenneth M. Peters, M.D., the Principal Investigator leading this study, is internationally known for his work on neuromodulation, interstitial cystitis, and painful bladder syndrome. Dr. Peters is the Chairman of the Department of Urology and Director of Clinical Research -- Depart
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
2. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
3. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
4. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
5. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
7. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
8. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. First European Patients Treated With the Percutaneous MitraClip(R) System
11. Trius Doses First Patient in Antibacterial Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... DALLAS , Sept. 19, 2014 ... Market Outlook to 2020″, provides key ... General Surgery devices market. The report ... dollars, and volume (in units) within ... Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, ...
(Date:9/19/2014)... According to the new ... therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, ... Global Forecast to 2019" published by MarketsandMarkets, the global ... Million by 2019 from $14,240.0 Million in 2014, ... 2019. Browse 74 market data tables ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: ... and Canada , is teaming with ... La Diabetes: Logra Tus Metas , an educational program encouraging Hispanics ... sugar -- a key treatment goal to help reduce the risk ... are at a higher risk for developing type 2 ...
Breaking Medicine Technology:United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... Scientific Resources, Inc. (OTCQB: ASFX) ("American Scientific Resources" ... Products) Ltd. ("Syner-Med") is the Company,s new distributor ... for its non-contact thermometers. Syner-Med placed an initial ... retail and professional models, of the VeraTemp non-contact ...
... LIVINGSTON, N.J., March 14 , 2011 Milestone ... develops, manufactures, and markets computer-controlled injection systems for medical ... has commenced trading on the OTCQB(TM) electronic quotation and ... not required to take any action as a result ...
Cached Medicine Technology:American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 2American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland 3Milestone Scientific Inc. Commences Trading on the OTC Pink 2
(Date:9/19/2014)... News) -- As kids transition from elementary to middle ... to a recent study. But the researchers ... that verbal and physical bullying declines as students get ... prevention strategies must address all types of bullying as ... the researchers said. The study was published recently in ...
(Date:9/19/2014)... 2014 Hastings and Hastings, a discount accident ... industry, announces a record number of visitors to its new ... of serious injury cases as well as auto accident cases ... related accident cases and others. Having served the state of ... the test of time when it comes to dedicated and ...
(Date:9/19/2014)... Rockville Centre, NY (PRWEB) September 19, 2014 ... 17, the manufacturers of the embattled blood-thinner Xarelto, named ... County Court of Common Pleas, have moved the court ... the cases do not have sufficient connection with Philadelphia.* ... & Development, et al. (No. 140304328; Pa. Comm. Pls., ...
(Date:9/19/2014)... News) -- Your brain structure could help predict how willing ... Researchers at Yale University found those with greater volume ... cortex may be more likely to engage in risky behavior ... The study, funded by the U.S. National Institute on Aging, ... in the Northeast. The researchers sought to determine how brain ...
(Date:9/19/2014)... (HealthDay News) -- The U.S. Food and Drug Administration approved ... is part of a class of once-a-week injectable drugs that ... diabetes. "Trulicity is a new treatment option, which ... to control blood sugar levels in the overall management of ... FDA,s Office of Drug Evaluation II, said in an agency ...
Breaking Medicine News(10 mins):Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2
... has estimated that nearly 55 percent of Americans, mostly ... of porous and brittle bones// that causes higher susceptibility ... has been found to contribute to lower bone mineral ... Katherine Tucker, PhD, director of the Epidemiology and Dietary ...
... (etanercept) safe to be used to treat psoriasis up to ... of the current studies were presented at the 15th European ... 'Biologic Medicine which means it is synthesized using recombinant DNA ... biotechnology. , , ,This biologic medicine acts by ...
... of daily physical exercise for their future good health, says ... 545 children at 36 nurseries in Glasgow. ,The ... of exercise - 30 minutes, three times a week, reported ... activity was not enough to affect the children's body mass ...
... its toll across India Thursday with over 40 people reported ... government maintained the situation did not merit an epidemic status. ... that of an epidemic and we expect that the number ... next two-three days. ,"So far we have recorded ...
... levels down for decades, ever since studies showed a strong ... years, experts have suggested that some people should aim even ... cholesterol called low-density lipoprotein for some high-risk people — even ... get there. ,Not so fast, says a team of ...
... some very interesting results following her study ... of alcoholics, which ultimately determine which drugs can be ... ,The urge to consume alcoholic drinks can be stifled ... by the researcher highlights which characteristics of a patient ...
Cached Medicine News:Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 2Health News:Consumption of Colas Increase Risk of Osteoporosis in Older Women 3Health News:Enbrelr Enters Safer Zone After Recent Research 2Health News:India registers 3,000 dengue patients, toll crosses 40 2Health News:India registers 3,000 dengue patients, toll crosses 40 3Health News:India registers 3,000 dengue patients, toll crosses 40 4Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 2Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 3Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 4